AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2016
Nov 14, 2016
31802_dirs_2016-11-14_568f6c30-f3fc-475f-add8-a6be2b281beb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2016-11-11
Reporting Person: WEHRWEIN SVEN (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-11 | Stock Option (right to buy) | $19.95 | A | 50000 | Acquired | 2026-11-11 | Common Stock (50000) | Direct |
Footnotes
F1: Exercisable cumulatively at a rate of 25% per annum commencing on the anniversary of the date of grant.
F2: Not applicable
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3